Development of two Salmonella-based oral vaccines against human respiratory syncytial virus

Development of two Salmonella-based oral vaccines against human respiratory syncytial virus

Human respiratory syncytial virus is the most common cause of bronchiolitis and other respiratory infections in infants and the elderly worldwide. We have developed two new oral vaccines using Salmonella typhi TY21a to carry and express the immunogenic epitopes of RSV fusion (F) and attachment (G) g...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Jalilian, F. Azizi, Yusoff, K., Suhaimi, S., Amini, R., Sekawi, Z., Jahanshiri, F.
Formaat:	Artikel
Gepubliceerd in:	BIOLIFE, s.a.s. 2015

Gelijkaardige items

Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
door: Suhaimi, Siti Syazani
Gepubliceerd in: (2011)

Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
door: Jalilian, Farid Azizi
Gepubliceerd in: (2011)

Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein.
door: Jalilian, Farid Azizi, et al.
Gepubliceerd in: (2011)

Vaccination against respiratory syncytial virus
door: Green, CA, et al.
Gepubliceerd in: (2020)

A Putative Oral Vaccine based on Live Lactococci Expressing the Surface Glycoproteins Respiratory Syncytial Virus.
door: Lim, Erin Swee Hua
Gepubliceerd in: (2010)

Respiratory syncytial virus vaccination during pregnancy and effects in infants
door: Madhi, SA, et al.
Gepubliceerd in: (2020)

Respiratory syncytial virus: Immunisation and prophylaxis
door: Barr, R, et al.
Gepubliceerd in: (2018)

Seasonality of respiratory syncytial virus infection.
door: Waris, M, et al.
Gepubliceerd in: (2006)

Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach
door: ul Qamar, Muhammad Tahir, et al.
Gepubliceerd in: (2020)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
door: Drysdale, S, et al.
Gepubliceerd in: (2020)

The recombinant nucleocapsid protein of Newcastle disease virus produced in yeast.
door: Jahanshiri, Fatemeh, et al.
Gepubliceerd in: (2010)

Respiratory syncytial virus infections in children and adults.
door: Collins, C, et al.
Gepubliceerd in: (2002)

Prevention of nosocomial respiratory syncytial virus infection.
door: O'Callaghan, C
Gepubliceerd in: (1993)

Respiratory syncytial virus: diagnosis, prevention and management
door: Barr, R, et al.
Gepubliceerd in: (2019)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)
door: Mahikul, W, et al.
Gepubliceerd in: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
door: Antepowicz, A, et al.
Gepubliceerd in: (2021)

Respiratory Syncytial Virus Consortium in Europe (RESCEU) birth cohort study: defining the burden of infant respiratory syncytial virus disease in Europe
door: Wildenbeest, JG, et al.
Gepubliceerd in: (2020)

Estimating transmission parameters for respiratory syncytial virus and predicting the impact of maternal and pediatric vaccination
door: Van Boven, M, et al.
Gepubliceerd in: (2020)

Display of respiratory syncytial virus epitopes on ferritin protein cage for potential application as vaccine
door: Law, Boyce Hong Ping
Gepubliceerd in: (2014)

Developing a novel vaccine for the prevention of severe disease caused by respiratory syncytial virus
door: Green, C
Gepubliceerd in: (2017)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
door: Green, C, et al.
Gepubliceerd in: (2015)

Burden of respiratory syncytial virus-associated acute respiratory infections during pregnancy
door: Kenmoe, S, et al.
Gepubliceerd in: (2023)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
door: Kinyanjui, T, et al.
Gepubliceerd in: (2020)

Meteorological drivers of respiratory syncytial virus infections in Singapore
door: Ali, Sheikh Taslim, et al.
Gepubliceerd in: (2021)

Respiratory syncytial virus assembly in epithelial cells and macrophages
door: Laxmi Ravi Iyer
Gepubliceerd in: (2014)

Respiratory syncytial virus--viral biology and the host response.
door: Hacking, D, et al.
Gepubliceerd in: (2002)

Transcriptomic analysis of biomarkers of respiratory syncytial virus disease
door: McGinley, J
Gepubliceerd in: (2020)

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
door: Lin, G-L, et al.
Gepubliceerd in: (2021)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
door: Antepowicz, A, et al.
Gepubliceerd in: (2018)

Respiratory syncytial virus and human metapneumovirus : the morphological and transmission studies
door: Nguyen, Huong Tra
Gepubliceerd in: (2017)

Respiratory syncytial virus seasonality and its implications on prevention strategies
door: Janet, S, et al.
Gepubliceerd in: (2017)

Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis.
door: Goetghebuer, T, et al.
Gepubliceerd in: (2004)

Global respiratory syncytial virus–related infant community deaths
door: Mazur, NI, et al.
Gepubliceerd in: (2021)

Molecular characteristics and transmission dynamics of human respiratory syncytial virus
door: Lin, GL
Gepubliceerd in: (2021)

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.
door: Wang, D, et al.
Gepubliceerd in: (2008)

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.
door: Wang, D, et al.
Gepubliceerd in: (2008)

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation
door: Wang, D, et al.
Gepubliceerd in: (2008)

Acute respiratory infections in hospitalized children in Vientiane, Lao PDR - the importance of Respiratory Syncytial Virus
door: Nguyen, V, et al.
Gepubliceerd in: (2017)

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
door: Billard, MN, et al.
Gepubliceerd in: (2022)

Diversity of respiratory viruses detected among hospitalized children with acute lower respiratory tract infections at Hospital Serdang, Malaysia
door: Etemadi, Mohammad Reza, et al.
Gepubliceerd in: (2019)